Boston Scientific Corporation (NYSE:BSX) Receives The CE Mark-Approval

910

Dallas, Texas 11/20/2013 (Financialstrend) – The Boston Scientific Corporation (NYSE:BSX) Vercise Deep Brain Stimulation System has received the CE Mark-approval. It is used in the treatment of intractable-primary & secondary dystonia, a neurological-movement disorder that is characterized by the involuntary muscle contractions.

Dystonia affects over 500,000 people in Europe, and included children and adults. This is the 3rd most-common movement-disorder after Parkinson’s disease & essential tremor. Its Symptoms are involuntary muscle contractions that are accompanied by twisting and repetitive movements / abnormal postures. All of these can be very painful & debilitating.
The Boston Scientific Corporation (NYSE:BSX) Vercise DBS System is the very 1st system that has been designed to selectively-stimulate different targeted areas of the human brain to customize therapy & manage Parkinson’s disease symptoms. This system offers new hope for those patients with dystonia.

Tuesday’s trading

In Tuesday’s trading session, Boston Scientific Corporation (NYSE:BSX) rose by 3.37%. The shares opened at a price of $11.63, which touched the intraday high of $12.05 and headed to a close of $11.96. Approximately 13.01M shares were traded on Tuesday and an average volume of 13.70 million shares were traded over a 30 day period. The 52-week low of Boston Scientific Corporation (NYSE:BSX) shares is $5.17 and its 52-week high is $12.48. The company has a market capitalization of $15.97 billion.

About the company

Boston Scientific Corporation (NYSE:BSX) is a company that develops, manufactures & markets medical devices that are utilized in a variety of different interventional medical specialties. In the year that ended in 31st December 2011, Boston Scientific Corporation (NYSE:BSX)’s products had been offered for sale by 7 core businesses: 1- Interventional Cardiology, 2- CRM, 3- Endoscopy, 4- Peripheral Interventions, 5- Urology/Women’s Health, 6- Neuromodulation, and 7- Electrophysiology. In 2011 January, Boston Scientific Corporation (NYSE:BSX) completed acquiring Intelect Medical, Inc. In 2012 June, Boston Scientific Corporation (NYSE:BSX) acquired Cameron Health, Inc. located in San Clemente, California

Subscribe to get your free report!

* indicates required
*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.